We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 341

The European Union’s highest court rules on standard-essential patents, injunctions and abuse of dominance
  • McDermott Will & Emery
  • European Union
  • August 27 2015

The long-awaited ruling regarding the circumstances under which the owner of a standard-essential patent (SEP) encumbered by fair, reasonable and


Lanham Act attorneys’ fees awarded in the absence of damages
  • McDermott Will & Emery
  • USA
  • August 31 2011

The U.S. Court of Appeals for the Ninth Circuit held that even in the absence of an award of damages on a Lanham Act false advertising claim, a party can recover attorneys’ fees after obtaining an injunction that confers substantial benefit to the public


Local wholesaler-retailer dispute has federal implications
  • McDermott Will & Emery
  • USA
  • October 16 2014

On August 14, the U.S. District Court for the Southern District of Mississippi issued an opinion finding that state regulations bolstered one


Third Circuit extends Actavis to reverse settlement agreements involving non-cash consideration
  • McDermott Will & Emery
  • USA
  • July 29 2015

Addressing for the first time whether reverse settlement agreements involving non-cash consideration merit antitrust scrutiny, the U.S. Court of


Reverse payment settlements subject to antitrust challenge
  • McDermott Will & Emery
  • USA
  • July 30 2015

In a class action case assessing the implications of antitrust law in a patent infringement and validity settlement agreement, the Supreme Court of


U.S. Supreme Court hears oral argument in Phoebe Putney hospital merger challenge
  • McDermott Will & Emery
  • USA
  • November 27 2012

In oral argument in FTC v Phoebe Putney Health System, Supreme Court Justices focused on whether the state legislature clearly articulated a state policy to displace competition with regulation, in a case challenging the application of the state action doctrine to a hospital merger to monopoly


The Advocate General of the EU clarifies position on enforcement of SEPs
  • McDermott Will & Emery
  • European Union, Germany
  • December 30 2014

Despite the fact that standard-essential patents (SEPs) have been on the agenda of the European Union (EU) competition law debate for some time now


Second Circuit to hear expedited appeal in “product hopping” suit
  • McDermott Will & Emery
  • USA
  • January 9 2015

On January 6, 2015, the Second Circuit granted defendants’ motion for an expedited appeal but denied their motion for a stay in New York v


Civil litigation under China’s Anti-Monopoly Law
  • McDermott Will & Emery
  • China
  • March 26 2012

Since the introduction of the China AML in August 2008, Chinese courts have experimented with various methods of civil dispute adjudication based on breach of the AML


The European Union’s highest court rules on standard-essential patents, injunctions and abuse of dominance
  • McDermott Will & Emery
  • European Union
  • July 23 2015

The long-awaited ruling on the seeking of injunctions in the context of standard-essential patents encumbered by fair, reasonable, and